Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing mini-HTAs of medical technologies in Norway in January 2020

Norway established in 2013 a framework for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. This framework is called the “New Method.”

In this framework, all innovations should undergo HTA before being funded. If the method concerns only one or two hospitals, the assessment shall be initiated by clinicians and ran at the hospital level. The final report is disseminated via a mini-HTA database. If the method is of national concern, it undergoes Single Technology Appraisal at the national level, followed by the funding decision by the group of payers (Decision Forum, Beslutningsforum).

In January 2020, four new mini-HTA projects of medical technologies were launched:

  • Continuous electroencephalography in patients with cardiac arrest (Oslo University Hospital)
  • Use of implant vs. autologous material in ear construction (Oslo University Hospital)
  • Inspiratory Muscle Training (Oslo University Hospital)
  • Robot-assisted thyroidectomy (University Hospital of North Norway)

The full list (in Norwegian) can be seen here

After completion of the assessment, hospital management will make a decision about the funding of studied technology in a particular hospital.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.